(Q40443588)

English

ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer

scientific article

Statements

ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer (English)
Christian Marth
Willi Oberaigner
Christian Kurzeder
Nicoletta Colombo
Vincent Renard
Sandro Pignata
Rebecca Kristeleit
Sevilay Altintas
Robert M Wenham
Mansoor Raza Mirza
Florian D Vogl

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit